SARAH SEATON: Open Payments
NPI 1275086324 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 63 payments from 12 companies in 2025. Trend: 2023 $144 · 2024 $82 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $228 |
| Axsome Therapeutics, Inc. | 17 | $189 |
| ABBVIE INC. | 14 | $156 |
| Alkermes, Inc. | 5 | $85 |
| Indivior Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $55 |
| Tris Pharma Inc | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
Products named: CAPLYTA, Auvelity, REXULTI, ARISTADA, SUBLOCADE, QULIPTA, VRAYLAR, LINZESS.
Industry payments across IN — which companies pay providers there.
